Anonymous
Guest
Anonymous
Guest
Medical-device maker Boston Scientific Corp. had goodwill write-downs in five of the last six years, but granted incentive pay to its CEO each year. The company had a $4.1 billion 2012 loss under standard accounting measures, but after excluding a $4.4 billion goodwill write-down and other charges, it had a $933 million profit used to set short-term incentive pay.
Citing confidentiality, a spokeswoman said the company doesn't comment on specifics about executive performance beyond its filings.
Write to Michael Rapoport at Michael.Rapoport@wsj.com
Citing confidentiality, a spokeswoman said the company doesn't comment on specifics about executive performance beyond its filings.
Write to Michael Rapoport at Michael.Rapoport@wsj.com